| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RIO
|
7,373.00 | 119.8B | 16.07 | 2.58 | 7.70 | 18.5% | 12.6% | 58 | 39 | 7,944.55 | +5.6% | 75 | 0.38 |
|
FRES
|
3,084.00 | 22.7B | 21.71 | 6.49 | 10.71 | 77.5% | 15.1% | 55 | 46 | 2,282.67 | -18.7% | 96 | 0.18 |
|
BHP
|
3,423.00 | 173.8B | 25.77 | 4.61 | 9.59 | 27.2% | 12.9% | 48 | 44 | 2,543.61 | -18.5% | 81 | 0.56 |
|
S32
|
252.20 | 11.3B | 70.09 | 1.62 | 11.18 | 9.5% | 14.5% | 46 | 27 | 200.25 | -14.8% | 79 | 0.18 |
|
GLEN
|
578.85 | 67.7B | — | 2.39 | 15.21 | 5.6% | 11.0% | 34 | 32 | 416.49 | -16.5% | 44 | 1.10 |
|
ANTO
|
4,009.00 | 39.5B | 63.72 | 5.43 | 14.24 | 11.6% | 14.3% | 33 | 25 | 1,882.70 | -39.8% | 82 | 0.65 |
|
AAL
|
4,203.00 | 45.4B | — | 3.14 | 21.81 | 15.3% | 13.1% | 30 | 31 | 2,277.52 | -29.3% | 56 | 0.88 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.